February 16, 2012 (Rockville, Maryland)— The US Food and Drug Administration (FDA) is notifying physicians that CardioGen-82 (Bracco Diagnostics), a generator used at clinical sites to produce the ...

July 26, 2011 (Rockville, Maryland)— The FDA is now telling physicians to stop using the CardioGen-82 cardiac positron-emission tomography (PET) scanner after issuing an earlier alert about a risk of ...

Monogenic cardiovascular disease is a genetic disease in which cardiovascular damage is the only or main phenotype. The total current number of patients worldwide exceeds 10 million. In 2019, the ...

BGI Genomics, together with the National Center for Cardiovascular Diseases, Fuwai Hospital, and the State Key Laboratory of Cardiovascular Diseases, is pleased to ...

Monogenic cardiovascular disease is a genetic disease in which cardiovascular damage is the only or main phenotype. The total current number of patients worldwide exceeds 10 million. In 2019, the ...

Please provide your email address to receive an email when new articles are posted on . The FDA is updating health care professionals and the public about preliminary findings from ongoing ...

Please provide your email address to receive an email when new articles are posted on . The FDA has issued a warning to healthcare professionals telling them to stop using CardioGen-82 due to the ...

Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, today announced the ...

Audentes Therapeutics said today it has acquired adeno-associated virus (AAV) gene therapy developer Cardiogen Sciences for an undisclosed price. Audentes said it plans to “rapidly” advance into ...

SAN FRANCISCO--(BUSINESS WIRE)--Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare ...